Gene Biotherapeutics, Inc. Purchase Agreements
14 Contracts & Agreements
- Asset Purchase Agreement dated July 15, 2018 between Activation Therapeutics, Inc. and Olaregen Therapeutix, Inc. for the sale of Excellagen (Filed With SEC on April 23, 2021)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 5, 2013)
- ASSET PURCHASE AGREEMENT BY AND AMONG TO GO BRANDS, INC. Seller, MEDPODIUM HEALTH PRODUCTS, INC., Buyer, AND CARDIUM THERAPEUTICS, INC., Owner of Buyer. Dated as of September 28,... (Filed With SEC on October 4, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 13, 2012)
- ASSET PURCHASE AGREEMENT DATED AS OF JUNE 26, 2011 BY AND AMONG TRANSDEL PHARMACEUTICALS, INC., AS SELLER AND CARDIUM HEALTHCARE, INC., AS PURCHASER AND CARDIUM THERAPEUTICS INC.... (Filed With SEC on June 27, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 15, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 15, 2009)
- ASSET PURCHASE AGREEMENT (Filed With SEC on July 15, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 21, 2008)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 30, 2008)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 31, 2008)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 6, 2007)
- ASSET PURCHASE AGREEMENT (Filed With SEC on August 15, 2006)
- ASSET PURCHASE AGREEMENT (Filed With SEC on March 14, 2006)